本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

泰坦製藥

3.85
+0.12023.22%
盤後3.70-0.1500-3.90%18:06 EDT
成交量:2.38萬
成交額:8.96萬
市值:351.98萬
市盈率:-0.74
高:3.93
開:3.80
低:3.65
收:3.73
資料載入中...
2022/07/11

重要事件披露

8-K - Current report
2022/07/08

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/07/05

重要事件披露

8-K - Current report
2022/06/09

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/02

重要事件披露

8-K - Current report
2022/05/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/06

重要事件披露

8-K - Current report
2022/04/25

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/04/04

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/03/31

SEC問詢函

CORRESP [Cover] - Correspondence
2022/03/31

SEC問詢函

CORRESP [Cover] - Correspondence
2022/03/28

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/03/25

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2022/02/03

重要事件披露

8-K - Current report
2022/01/24

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/03

重要事件披露

8-K - Current report
2021/12/29

重要事件披露

8-K - Current report
2021/12/22

重要事件披露

8-K - Current report